Only 4 of the 89 tumor specimens with successful IHC staining tested negative for B7-H3 expression; all four of these B7-H3–negative samples were from the 15 patients with nonmeasurable neuroblastoma. This evidence concerns the gene CD276 and neuroblastoma.